A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis
Abstract
Metabonomic/metabolomic studies can involve the analysis of large numbers of samples for the detection of
* Corresponding authors
a
Dept. of Drug Metabolism and Pharmacokinetics, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK
E-mail:
ian.wilson@astrazeneca.com
b Waters Corporation, Atlas Park, Manchester, UK
c Waters Corporation, 34 Maple Street, Milford, MA, USA
Metabonomic/metabolomic studies can involve the analysis of large numbers of samples for the detection of
T. Sangster, H. Major, R. Plumb, A. J. Wilson and I. D. Wilson, Analyst, 2006, 131, 1075 DOI: 10.1039/B604498K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content